Clinical Trial Update: Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating donor stem cell transplantation followed by cyclophosphamide for hematological diseases; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Hematopoietic Lymphoid Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-10-11